Lemba Therapeutics
non-coding genome RNA medicines
- B2B
About Lemba Therapeutics
Unlocking non-coding genome therapeutic potential, creating RNA medicines targeting lncRNAs to treat inflammation, cancer, metabolic disorders, and autoimmune diseases, using functional genomics and AI.
Key facts
- Industry
- Biotechnology Research
- Company size
- 11–50 employees
- Headquarters
- Nijmegen, Gelderland, Netherlands
- Founded
- 2020
- Revenue
- $8.4M – $66.1MTamtam estimate
Lemba Therapeutics at a glance
Lemba Therapeutics is a B2B company in the Biotechnology Research industry, headquartered in Nijmegen, Gelderland, Netherlands.
Lemba Therapeutics was founded in 2020.
Lemba Therapeutics has 11–50 employees.
Lemba Therapeutics's revenue is $8.4M – $66.1M (Tamtam estimate).
Frequently asked questions about Lemba Therapeutics
What is Lemba Therapeutics's revenue?
Tamtam estimates Lemba Therapeutics's annual revenue at $8.4M – $66.1M.
How many employees does Lemba Therapeutics have?
Lemba Therapeutics has 11–50 employees.
Where is Lemba Therapeutics headquartered?
Lemba Therapeutics is headquartered in Nijmegen, Gelderland, Netherlands.
Selling to companies like Lemba Therapeutics?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies